Pathogenesis of glomerulonephritis;Mécanismes des glomérulonéphrites immunes

Revue du Praticien

Volumn 53, Issue 18, 2003, Pages 1998-2004

  Rougier, Jean Philippe ^a   Ronco, Pierre ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; IMMUNOGLOBULIN A;

EFFECTOR CELL; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HELPER CELL; IMMUNE COMPLEX NEPHRITIS; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; KIDNEY FAILURE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOGLOBULINS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; LYMPHOCYTE SUBSETS; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; RABBITS; RATS; RECURRENCE; T-LYMPHOCYTES;

EID: 0347513047     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int 1980; 17: 1-13.
2. Hudson BG, Kalluri R, Gunwar S, Noelken ME, Mariyama M, Reeders ST. Molecular characteristics of the Goodpasture autoantigen. Kidney Int 1993; 43: 135-9.
3. Yoshizawa N, Oshima S, Sagel I, Shimizu J, Treser G. Role of a streptococcal antigen in the pathogenesis of acute poststreptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease. J Immunol 1992; 148: 3110-6.
4. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556-60.
5. Cunard R, Kelly CJ. T cells and minimal change disease. J Am Soc Nephrol 2002; 13: 1409-11.
6. Lai KN, Ho RT, Lai CK, Chan CH, Li PK. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 1994; 96: 116-21.
7. Wu H, Clarkson AR, Knight JF. Restricted gamma-delta T-cell receptor repertoire in IgA nephropathy renal biopsies. Kidney Int 2001; 60: 1324-31.
8. Patrakka J, Ruotsalainen V, Reponen P et al. Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation 2002; 73: 394-403.
9. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-508.
10. Berger J, Hinglais N. [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris) 1968; 74: 694-5.
11. Novak J, Julian BA, Tomana M, Mesteck J. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 2001; 21: 310-27.
12. Feehally J, Allen AC. Pathogenesis of IgA nephropathy. Ann Med Interne (Paris) 1999; 150: 91-8.
13. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760-9.
14. Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13: 930-4.
15. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-85.
16. Lai KN, Ho RT, Leung JC, Lai FM, Li PK. Increased mRNA encoding for transforming factor-beta in CD4+ cells from patients with IgA nephropathy. Kidney Int 1994; 46: 862-8.
17. Fujihashi K, McGhee JR, Kweon MN et al. gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med 1996; 183: 1929-35.
18. Chen A, Chen WP, Sheu LF, Lin CY. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 1994; 173: 119-26.
19. Gomez-Guerrero C, Gonzalez E, Egido J. Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol 1993; 151: 7172-81.
20. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. IgA and the IgA Fc receptor. Trends Immunol 2001; 22: 205-11.
21. Monteiro RC, Moura IC, Launay P et al. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol Med 2002; 8: 464-8.
22. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997; 159: 3474-82.
23. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL. Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 1959; 100: 660-4.
24. Saito A, Pietromonaco S, Loo AK, Farquhar MG. Complete cloning and sequencing of rat gp330/«megalin» a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci U S A 1994; 91: 9725-9.
25. Horl WH, Kerjaschki D. Membranous glomerulonephritis (MGN). J Nephrol 2000; 13: 291-316.
26. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 1999; 56: 355-77.
27. Assmann KJ, Ronco P, Tangelder MM, Lange WP, Verroust P, Koene RA. Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat. Am J Pathol 1985; 121: 112-22.
28. Ronco P, Allegri L, Brianti E, Chatelet F, Van Leer EH, Verroust P. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology. Appl Pathol 1989; 7: 85-98.
29. Ronco PM, Ardaillou N, Verroust P, Lelongt B. Pathophysiology of the podocyte: a target and a major player in glomerulonephritis. Adv Nephrol Necker Hosp 1994; 23: 91-131.
30. Debiec H, Guigonis V, Mougenot B et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-60.
31. Dantal J, Giral M, Hoormant M, Soulillou JP. Glomerulonephritis recurrences after kidney transplantation. Curr Opin Nephrol Hypertens 1995; 4: 146-54.
32. Lagrue G, Branellec A, Blanc C et al. A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties. Biomedicine 1975; 23: 73-5.
33. Cochat P, Kassir A, Colon S et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993; 7: 50-4.
34. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14.
35. Dantal J, Godfrin Y, Koll R et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998; 9: 1709-15.
36. Le Berre L, Godfrin Y, Gunther E et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 2002; 109: 491-8.
37. Sahali D, Pawlak A, Le Gouvello S et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 2001; 12: 1648-58.
38. Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B. T-lymphocyte subsets in nephrotic syndrome. Kidney Int 1991; 40: 913-6.
39. Sahali D, Pawlak A, Valanciute A et al. A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening. J Am Soc Nephrol 2002; 13: 1238-47.
40. Garin EH, Blanchard DK, Matsushima K, Djeu JY. IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 1994; 45: 1311-7.